Generic diabetes pill put to the test: will it match the brand?
NCT ID NCT07679711
First seen Jul 01, 2026 · Last updated Jul 01, 2026
Summary
This trial tests whether a new generic extended-release tablet containing sitagliptin and metformin works the same in the body as the brand-name version (Janumet XR). Healthy Chinese adults receive a single dose of each tablet, separated by a washout period, under both fasting and fed conditions. Blood samples are taken to measure drug levels and check for safety. The goal is to see if the generic can be considered a suitable substitute for the brand.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Sitagliptin/Metformin hydrochloride extended-release tablet
What this could lead to
If the test tablet proves equivalent to the reference, it could offer a more affordable generic option for managing type 2 diabetes.
What could go wrong
This is an early-phase bioequivalence study in healthy volunteers, not patients. Results may not predict real-world effectiveness or safety in people with diabetes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Affiliated Hospital of Qingdao University
Qingdao, Shandong, 266000, China